Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.7000 (-0.39%) ($7.7000 - $7.7000) on Fri. May. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.36% (three month average) | RSI | 50 | Latest Price | $7.7000(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.8% a day on average for past five trading days. | Weekly Trend | ANPC advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(10%) XLB(10%) LIT(9%) HYG(8%) IPO(8%) | Factors Impacting ANPC price | ANPC will decline at least -2.68% in a week (0% probabilities). SHY(-15%) XBI(-7%) IBB(-6%) XLU(-5%) XLP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.68% (StdDev 5.36%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.74 | 5 Day Moving Average | $7.76(-0.77%) | 10 Day Moving Average | $7.9(-2.53%) | 20 Day Moving Average | $7.74(-0.52%) | To recent high | -26.5% | To recent low | 8.9% | Market Cap | $66m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |